ETXPF
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Apr 16 closing price
Capitalization
75.96M
HOFBF
Price
$0.15
Change
+$0.06 (+60.00%)
Updated
Apr 14 closing price
Capitalization
68.73M
Interact to see
Advertisement

ETXPF vs HOFBF

Header iconETXPF vs HOFBF Comparison
Open Charts ETXPF vs HOFBFBanner chart's image
E-Therapeutics
Price$0.13
Change-$0.01 (-7.14%)
Volume$10K
Capitalization75.96M
Hofseth Biocare ASA
Price$0.15
Change+$0.06 (+60.00%)
Volume$400
Capitalization68.73M
ETXPF vs HOFBF Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ETXPF vs. HOFBF commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETXPF is a StrongBuy and HOFBF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (ETXPF: $0.13 vs. HOFBF: $0.16)
Brand notoriety: ETXPF and HOFBF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ETXPF: 100% vs. HOFBF: 100%
Market capitalization -- ETXPF: $75.96M vs. HOFBF: $68.73M
ETXPF [@Biotechnology] is valued at $75.96M. HOFBF’s [@Biotechnology] market capitalization is $68.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETXPF’s FA Score shows that 0 FA rating(s) are green whileHOFBF’s FA Score has 0 green FA rating(s).

  • ETXPF’s FA Score: 0 green, 5 red.
  • HOFBF’s FA Score: 0 green, 5 red.
According to our system of comparison, HOFBF is a better buy in the long-term than ETXPF.

Price Growth

ETXPF (@Biotechnology) experienced а 0.00% price change this week, while HOFBF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
ETXPF($76M) has a higher market cap than HOFBF($68.7M). HOFBF YTD gains are higher at: 55.000 vs. ETXPF (0.000).
ETXPFHOFBFETXPF / HOFBF
Capitalization76M68.7M111%
EBITDAN/A-73.54M-
Gain YTD0.00055.000-
P/E RatioN/AN/A-
RevenueN/A266M-
Total CashN/A71.9M-
Total DebtN/A236M-
FUNDAMENTALS RATINGS
HOFBF: Fundamental Ratings
HOFBF
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BMEZ14.420.07
+0.49%
BlackRock Health Sciences Term Trust
QLV67.640.14
+0.21%
FlexShares US Quality Low Vol ETF
BKLN20.900.03
+0.14%
Invesco Senior Loan ETF
KIO12.530.01
+0.08%
KKR Income OPPORTUNITIES FUND
IBIH26.33-0.03
-0.13%
iShares iBonds Oct 2031 Term Tips ETF

ETXPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETXPF has been loosely correlated with HOFBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ETXPF jumps, then HOFBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETXPF
1D Price
Change %
ETXPF100%
N/A
HOFBF - ETXPF
38%
Loosely correlated
N/A
BOLD - ETXPF
32%
Poorly correlated
-3.74%
KOD - ETXPF
23%
Poorly correlated
-2.38%
KTTA - ETXPF
6%
Poorly correlated
+3.41%
RANI - ETXPF
3%
Poorly correlated
+6.50%
More

HOFBF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOFBF has been loosely correlated with BIVI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HOFBF jumps, then BIVI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOFBF
1D Price
Change %
HOFBF100%
N/A
BIVI - HOFBF
44%
Loosely correlated
-1.94%
ETXPF - HOFBF
38%
Loosely correlated
N/A
PHGE - HOFBF
35%
Loosely correlated
-2.22%
INNMF - HOFBF
23%
Poorly correlated
+61.64%
IGXT - HOFBF
14%
Poorly correlated
N/A
More